Business / Finance

RSS

Metropolitan enters definitive merger agreement to acquire Continucare

Metropolitan Health Networks, Inc. and Continucare Corporation announced jointly today that they have entered into a definitive merger agreement whereby Metropolitan will acquire Continucare in a cash and stock transaction valued at approximately $416 million at the time of announcement.

27 Jun 2011

Youngevity to acquire Bellamora

Youngevity Essential Life Sciences, which sells an extensive line of nutritional supplements and health and personal care products, announced today that it has signed a definitive agreement to acquire the distributor base and product line of Bellamora, a Tampa, Florida-based marketer of skin care products.

27 Jun 2011

Derma Sciences announces $29 million financing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has closed its previously announced private placement.

27 Jun 2011

UHC inaugurates new 77,109-square-foot headquarters in Chicago

UHC, a national organization representing 90 percent of the nation's academic medical centers, has announced the opening of its new headquarters in downtown Chicago.

27 Jun 2011

Philips to acquire Sectra's mammography modality operations

Sectra and Royal Philips Electronics have signed an agreement under which Philips will acquire Sectra's mammography modality operations. The cash purchase consideration amounts to EUR 57.5 million on cash and debt-free basis.

27 Jun 2011

Bonovo forms new division to accelerate growth of hip and knee products

Bonovo Orthopedics, Inc. announced today that it has formed Bonovo Recon, a new division dedicated to accelerating the growth of Bonovo's hip and knee product development and sales initiatives.

27 Jun 2011

EMA approves Shire's new REPLAGAL manufacturing facility in Lexington

Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.

24 Jun 2011

Nutrastar opens Harbin specialty store in central Nangang District

Nutrastar International Inc., a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, today announced the opening of its second branded specialty store in Harbin. The store carries the company's core Cordyceps product and all of the Company's functional health beverage products.

24 Jun 2011

athenahealth announces new client and employee training center at Point Lookout facility

athenahealth, Inc., a leading provider of cloud-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced that it has closed on the purchase of property in Northport, Maine for $7.7 million.

24 Jun 2011

ABA honors Acorda Therapeutics president with 2011 Stevie Award

Acorda Therapeutics, Inc. announced that Ron Cohen, M.D., President and CEO of Acorda Therapeutics, was awarded the 2011 Stevie Award for Executive of the Year in the Health Products & Services category at the 9th Annual American Business Awards (ABA) ceremony held on June 20, 2011.

24 Jun 2011

Youngevity announces acquisition of R-Garden

Youngevity Essential Life Sciences, an international nutritional products company, announced its acquisition of R-Garden, Inc. The acquisition of R-Garden's Customers, Distributors, and Product Line expands Youngevity's already substantial "network cloud" of Distributors and Customers and their social networking reach.

24 Jun 2011

Clinical trial management systems market to reach over $1.76B by 2017

It is expected that the clinical trial management systems (CTMS) market will achieve a value of $1.76 billion by 2017, according to a new report on companiesandmarkets.com.

24 Jun 2011

Electrophysiology mapping and ablation devices market to reach over $2.1B by 2017

By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.

24 Jun 2011

BioMarin to acquire Pfizer's Ireland manufacturing plant

BioMarin Pharmaceutical Inc. announced today that it has entered into a definitive agreement to acquire a bulk biologics manufacturing plant from Pfizer, located in Shanbally, Cork, Ireland.

24 Jun 2011

Centrix and CutisPharma enter promotional agreement for vaginal suppository compounding kits

Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company.

23 Jun 2011

Cyanotech fourth quarter revenues increase to $5,218,000

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

23 Jun 2011

PNP Pharmaceuticals contracted as exclusive global manufacturer of Fero Industries' Sucanon

Fero Industries, Inc. is pleased to announce that it has contracted PNP Pharmaceuticals Inc. as the exclusive global manufacturer of Sucanon®, an oral treatment for type-2 diabetes.

23 Jun 2011

Rite Aid reports net loss of $63.1 million for first quarter ended May 28, 2011

Rite Aid Corporation today reported financial results for the first quarter ended May 28, 2011.

23 Jun 2011

Biosign grants 3,115,000 stock options at $0.92 per share

Biosign Technologies Inc. announced today the grant of an aggregate of 3,115,000 stock options pursuant to the Company's stock option plan. An aggregate of 1,115,000 of such options were granted effective June 16, 2011 to four directors of the Company.

23 Jun 2011

Insight into future development of global pharmaceutical industry

Alacrita, which is changing the face of life science consulting, has published an insight into the future development of the global pharmaceutical industry.

23 Jun 2011